Filtering by:

For the second time, the US Food and Drug Administration (FDA) has approved a drug to treat tumors with a specific genetic change regardless of the type of cancer. Vitrakvi (larotrectinib) is for adults and children with solid tumors that test positive for NTRK genes, which can help cancerous tumors grow.

The US Food and Drug Administration (FDA) has approved a combination of 2 targeted drugs to treat people with anaplastic thyroid cancer that has a certain type of gene mutation (BRAF V600E) and cannot be completely removed through surgery.

Cowden disease is a type of PTEN hamartoma tumor syndrome (PHTS) caused by a mutation in the PTEN gene. PHTS raises the risk of developing certain types of cancer, including skin, thyroid, breast, endometrial, colorectal, and kidney.

Luke Soderling says the lessons he learned from facing the challenges of thyroid cancer helped him to survive 60 days in 6 different harsh locations in South America, on the Discovery Channel show, The Wheel.

Lesly Gregory hasn’t always made a big deal out of being a cancer survivor. But this year she is throwing a party and inviting family and friends to help her celebrate 15 years since having thyroid cancer.